Infantile Spasms (West Syndrome)

Definition and Epidemiology

Infantile Spasms (IS) or West Syndrome is a severe age-dependent epileptic encephalopathy characterized by the triad of:

• Epileptic spasms
• Hypsarrhythmia on EEG
• Developmental regression/arrest

Epidemiology:

• Incidence: 2-3.5 per 10,000 live births
• Peak age of onset: 3-7 months
• Male predominance (ratio 1.5:1)
• 90% onset before 12 months of age

Etiology and Classification

Etiological Classification:

1. Genetic Causes:

• Chromosomal abnormalities:
  • Down syndrome
  • Miller-Dieker syndrome
  • 1p36 deletion
• Single gene disorders:
  • TSC1/TSC2 mutations (Tuberous Sclerosis Complex)
  • ARX mutations
  • CDKL5 mutations
  • STXBP1 mutations
  • FOXG1 mutations

2. Structural-Metabolic Causes:

• Perinatal brain injury:
  • Hypoxic-ischemic encephalopathy
  • Stroke
  • Infections
• Brain malformations:
  • Cortical dysplasia
  • Lissencephaly
  • Polymicrogyria
  • Schizencephaly
• Metabolic disorders:
  • Phenylketonuria
  • Mitochondrial disorders
  • Pyridoxine dependency
  • Nonketotic hyperglycinemia

3. Unknown Causes:

• Approximately 20% of cases
• Typically better prognosis

Clinical Manifestations

1. Epileptic Spasms:

• Characteristics:
  • Sudden, brief (1-2 seconds) axial contractions
  • Often occur in clusters
  • Typically upon awakening or during drowsiness
• Types:
  • Flexor spasms (most common)
  • Extensor spasms
  • Mixed spasms
  • Asymmetric spasms
• Associated features:
  • Crying during/after clusters
  • Autonomic changes
  • Eye deviation

2. EEG Findings:

• Hypsarrhythmia:
  • High amplitude (>200 µV)
  • Disorganized background
  • Multifocal spikes
  • Slow waves
• Variants:
  • Modified hypsarrhythmia
  • Asymmetric hypsarrhythmia
  • Hemihypsarrhythmia

3. Developmental Impact:

• Regression/arrest patterns:
  • Loss of visual attention
  • Loss of social smile
  • Loss of head control
  • Loss of previously acquired skills
• Associated features:
  • Irritability
  • Sleep disturbances
  • Feeding difficulties

Diagnosis and Evaluation

1. Essential Diagnostic Workup:

• Clinical history:
  • Detailed developmental history
  • Seizure semiology
  • Family history
  • Pregnancy and birth history
• Video-EEG monitoring:
  • Minimum 24 hours
  • Sleep and wake cycles
  • Documentation of spasms
• Neuroimaging:
  • MRI brain with contrast
  • Special sequences as needed

2. Additional Investigations:

• Genetic testing:
  • Chromosomal microarray
  • Epilepsy gene panel
  • Whole exome sequencing
• Metabolic screening:
  • Amino acids
  • Organic acids
  • Lactate/pyruvate
  • CSF studies
• Ophthalmological examination

Treatment

1. First-Line Treatments:

• Hormonal Therapy:
  • ACTH:
    • Natural or synthetic
    • Typical dose: 150 IU/m²/day
    • Duration: 2-4 weeks with taper
  • Oral Corticosteroids:
    • Prednisolone: 40-60 mg/day
    • Alternative to ACTH
• Vigabatrin:
  • First-line for TSC
  • Dose: 100-150 mg/kg/day
  • Regular ophthalmological monitoring

2. Second-Line Treatments:

• Topiramate
• Valproic acid
• Zonisamide
• Ketogenic diet
• Combination therapy

3. Monitoring During Treatment:

• Clinical response monitoring:
  • Spasm frequency
  • Development
  • Side effects
• Laboratory monitoring:
  • Blood pressure
  • Electrolytes
  • Blood glucose
  • Complete blood count
• EEG monitoring:
  • Resolution of hypsarrhythmia
  • Emergence of other patterns

Prognosis and Long-term Outcomes

Prognostic Factors:

• Favorable:
  • Cryptogenic etiology
  • Early treatment initiation
  • Rapid response to treatment
  • Normal development before onset
• Poor:
  • Symptomatic etiology
  • Delayed treatment
  • Associated neurological abnormalities
  • Early age of onset

Long-term Outcomes:

• Development:
  • 70-90% developmental delay
  • Autism spectrum disorders
  • Learning disabilities
• Epilepsy:
  • Evolution to other seizure types
  • Lennox-Gastaut syndrome
  • Refractory epilepsy
• Mortality:
  • 5-30% mortality rate
  • Higher in symptomatic cases

References and Further Reading

1. Pellock JM, et al. Infantile spasms: A U.S. consensus report. Epilepsia. 2010;51:2175-89.
2. Go CY, et al. Evidence-based guideline update: Medical treatment of infantile spasms. Neurology. 2012;78:1974-80.
3. Wirrell EC, et al. Optimizing the Diagnosis and Management of Infantile Spasms. Pediatr Neurol. 2015;53:487-92.
4. Pavone P, et al. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain Dev. 2014;36:739-51.

Note: This document is intended for medical professionals and should be regularly updated based on new research and guidelines. Clinical judgment should always be exercised in the management of individual patients.

Infantile Spasms (West Syndrome): Objective QandA

1. What is Infantile Spasms (West Syndrome)?
   Infantile Spasms, also known as West Syndrome, is a severe epileptic encephalopathy characterized by epileptic spasms, developmental regression, and a specific EEG pattern called hypsarrhythmia.
2. At what age do Infantile Spasms typically begin?
   Infantile Spasms typically begin between 3 and 12 months of age, with a peak onset around 6 months.
3. What are the characteristic features of epileptic spasms?
   Epileptic spasms are brief, sudden flexion or extension of the trunk and limbs, often occurring in clusters.
4. What is hypsarrhythmia?
   Hypsarrhythmia is a chaotic, high-voltage, disorganized EEG pattern that is characteristic of Infantile Spasms.
5. What are some common etiologies of Infantile Spasms?
   Common etiologies include genetic disorders, brain malformations, hypoxic-ischemic injury, tuberous sclerosis complex, and in some cases, unknown causes (cryptogenic).
6. How is the diagnosis of Infantile Spasms typically made?
   Diagnosis is based on the clinical presentation of epileptic spasms, developmental regression or arrest, and the presence of hypsarrhythmia on EEG.
7. What is the first-line treatment for Infantile Spasms?
   First-line treatments for Infantile Spasms include hormonal therapy (ACTH or oral corticosteroids) and vigabatrin.
8. Why is rapid initiation of treatment crucial in Infantile Spasms?
   Rapid treatment initiation is crucial because delay in effective treatment is associated with worse cognitive outcomes and more difficult-to-control epilepsy.
9. What is the role of vigabatrin in treating Infantile Spasms?
   Vigabatrin is particularly effective for Infantile Spasms associated with tuberous sclerosis complex and is one of the first-line treatment options.
10. What are the potential side effects of ACTH treatment for Infantile Spasms?
    Potential side effects of ACTH include hypertension, irritability, immune suppression, and electrolyte imbalances.
11. How does the ketogenic diet factor into the treatment of Infantile Spasms?
    The ketogenic diet can be an effective alternative or adjunctive treatment for Infantile Spasms, particularly in cases refractory to standard therapies.
12. What is the prognosis for patients with Infantile Spasms?
    The prognosis varies widely depending on the underlying etiology and treatment response, but many patients develop long-term cognitive impairment and epilepsy.
13. How does tuberous sclerosis complex relate to Infantile Spasms?
    Tuberous sclerosis complex is one of the most common identifiable causes of Infantile Spasms, accounting for about 10-30% of cases.
14. What is the importance of video EEG in diagnosing and managing Infantile Spasms?
    Video EEG is crucial for confirming the diagnosis of Infantile Spasms, differentiating spasms from other movement disorders, and assessing treatment response.
15. How does Infantile Spasms affect cognitive development?
    Infantile Spasms often lead to developmental regression or arrest, and many patients develop long-term cognitive impairment.
16. What is the role of genetic testing in Infantile Spasms?
    Genetic testing can identify underlying causes in up to 30% of cases, which may have implications for treatment, prognosis, and genetic counseling.
17. How do Infantile Spasms differ from benign myoclonus of infancy?
    Unlike Infantile Spasms, benign myoclonus of infancy does not involve developmental regression, hypsarrhythmia on EEG, or progression to other seizure types.
18. What is the significance of focal cortical dysplasia in Infantile Spasms?
    Focal cortical dysplasia is an important cause of Infantile Spasms and may be amenable to surgical treatment if medical therapy fails.
19. How does the presentation of Infantile Spasms change over time?
    As children age, the classic spasms may evolve into other seizure types, and the EEG may transition from hypsarrhythmia to other epileptiform patterns.
20. What is the role of neuroimaging in the evaluation of Infantile Spasms?
    Neuroimaging, particularly MRI, is essential to identify structural brain abnormalities that may be causing Infantile Spasms.
21. How does the treatment approach differ for Infantile Spasms due to tuberous sclerosis complex?
    Vigabatrin is typically the first-line treatment for Infantile Spasms associated with tuberous sclerosis complex due to its high efficacy in this population.
22. What is the concept of "electroclinical dissociation" in Infantile Spasms?
    Electroclinical dissociation refers to the persistence of hypsarrhythmia on EEG despite resolution of clinical spasms, which may still require treatment.
23. How does the ketogenic diet work in treating Infantile Spasms?
    The ketogenic diet is thought to work by altering brain metabolism and neurotransmitter systems, potentially leading to improved seizure control.
24. What is the role of pyridoxine (Vitamin B6) in treating Infantile Spasms?
    Pyridoxine can be effective in rare cases of Infantile Spasms caused by pyridoxine-dependent epilepsy and is sometimes used as a diagnostic trial.
25. How does the presence of Infantile Spasms affect long-term epilepsy risk?
    Many children with Infantile Spasms go on to develop other forms of epilepsy, including Lennox-Gastaut syndrome in some cases.
26. What is the importance of early recognition of Infantile Spasms?
    Early recognition and treatment of Infantile Spasms is crucial for improving developmental outcomes and reducing the risk of long-term epilepsy.
27. How do Infantile Spasms affect sleep patterns?
    Infantile Spasms can significantly disrupt sleep patterns, with spasms often occurring in clusters upon awakening.
28. What is the role of epilepsy surgery in treating Infantile Spasms?
    Epilepsy surgery may be considered in cases of focal brain lesions causing drug-resistant Infantile Spasms.
29. How does the presence of Infantile Spasms impact family dynamics?
    Infantile Spasms can have significant psychosocial impacts on families, including high stress levels, financial burden, and effects on siblings and parental relationships.
30. What is the role of EEG monitoring in assessing treatment response in Infantile Spasms?
    EEG monitoring is crucial for assessing treatment response, as resolution of hypsarrhythmia is an important marker of treatment success.
31. How does the treatment of Infantile Spasms differ from that of other childhood epilepsies?
    Treatment of Infantile Spasms often involves specific therapies like ACTH or vigabatrin, which are not typically first-line treatments for other childhood epilepsies.
32. What is the importance of developmental therapy in managing Infantile Spasms?
    Early intervention with developmental therapies (e.g., physical, occupational, speech therapy) is crucial to address developmental delays associated with Infantile Spasms.
33. How do Infantile Spasms affect feeding and nutrition?
    Infantile Spasms can affect feeding due to oropharyngeal dysfunction, which may lead to nutritional deficiencies and growth problems.
34. What is the role of cannabidiol (CBD) in treating Infantile Spasms?
    While not a first-line treatment, CBD has shown some promise in treating refractory Infantile Spasms and is being studied further.
35. How does the presence of Infantile Spasms affect long-term educational planning?
    Many children with a history of Infantile Spasms require special education services due to cognitive and developmental impairments.
36. What is the importance of genetic counseling for families affected by Infantile Spasms?
    Genetic counseling is important for families to understand the risk of recurrence in future pregnancies and potential implications for other family members.
37. How do Infantile Spasms affect visual development?
    Infantile Spasms can affect visual development, with some children developing cortical visual impairment.
38. What is the role of immunotherapy in treating Infantile Spasms?
    Immunotherapy, such as intravenous immunoglobulin or steroid pulse therapy, may be considered in some cases of Infantile Spasms, particularly those with suspected autoimmune etiology.
39. How does the timing of treatment initiation affect outcomes in Infantile Spasms?
    Earlier treatment initiation is associated with better cognitive and developmental outcomes, emphasizing the importance of prompt diagnosis and treatment.

Disclaimer

The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.